

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | imidazole-containing compound metabolic process (GO:0052803) | 9.45235165 |
| 2 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 7.03748358 |
| 3 | positive regulation of mast cell degranulation (GO:0043306) | 7.03748358 |
| 4 | regulation of T cell tolerance induction (GO:0002664) | 6.52376296 |
| 5 | positive regulation of mast cell activation (GO:0033005) | 5.66636703 |
| 6 | regulation of tolerance induction (GO:0002643) | 5.60282434 |
| 7 | T cell apoptotic process (GO:0070231) | 5.28578724 |
| 8 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 5.23851155 |
| 9 | regulation of mast cell activation involved in immune response (GO:0033006) | 5.21750225 |
| 10 | angiotensin maturation (GO:0002003) | 5.13540810 |
| 11 | regulation of T cell cytokine production (GO:0002724) | 5.00841532 |
| 12 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.98359623 |
| 13 | positive regulation of leukocyte degranulation (GO:0043302) | 4.88031219 |
| 14 | regulation of mast cell degranulation (GO:0043304) | 4.59007286 |
| 15 | lymphocyte apoptotic process (GO:0070227) | 4.43687589 |
| 16 | cellular biogenic amine biosynthetic process (GO:0042401) | 4.17809535 |
| 17 | amine biosynthetic process (GO:0009309) | 4.15411468 |
| 18 | regulation of mast cell activation (GO:0033003) | 4.01155515 |
| 19 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.94586452 |
| 20 | leukocyte apoptotic process (GO:0071887) | 3.89634117 |
| 21 | peroxisome fission (GO:0016559) | 3.88966336 |
| 22 | catecholamine biosynthetic process (GO:0042423) | 3.86596911 |
| 23 | catechol-containing compound biosynthetic process (GO:0009713) | 3.86596911 |
| 24 | regulation of B cell apoptotic process (GO:0002902) | 3.59618419 |
| 25 | regulation of chemokine biosynthetic process (GO:0045073) | 3.51442975 |
| 26 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.49784629 |
| 27 | positive regulation of regulated secretory pathway (GO:1903307) | 3.44697052 |
| 28 | deoxyribonucleotide catabolic process (GO:0009264) | 3.37214254 |
| 29 | deoxyribose phosphate catabolic process (GO:0046386) | 3.36555995 |
| 30 | lipoxygenase pathway (GO:0019372) | 3.34030329 |
| 31 | endosome to pigment granule transport (GO:0043485) | 3.33305439 |
| 32 | endosome to melanosome transport (GO:0035646) | 3.33305439 |
| 33 | regulation of leukocyte degranulation (GO:0043300) | 3.32591059 |
| 34 | ubiquinone biosynthetic process (GO:0006744) | 3.28506520 |
| 35 | purine-containing compound salvage (GO:0043101) | 3.21715997 |
| 36 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.16349571 |
| 37 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.12912465 |
| 38 | cellular response to exogenous dsRNA (GO:0071360) | 3.10944066 |
| 39 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.10602348 |
| 40 | purine nucleotide salvage (GO:0032261) | 3.06800994 |
| 41 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.04692427 |
| 42 | urate metabolic process (GO:0046415) | 3.04272143 |
| 43 | mature B cell differentiation involved in immune response (GO:0002313) | 3.03063058 |
| 44 | regulation of activated T cell proliferation (GO:0046006) | 2.93133543 |
| 45 | regulation of skeletal muscle contraction (GO:0014819) | 2.87777477 |
| 46 | AMP metabolic process (GO:0046033) | 2.85748578 |
| 47 | quinone biosynthetic process (GO:1901663) | 2.85551343 |
| 48 | regulation of glucokinase activity (GO:0033131) | 2.83352553 |
| 49 | regulation of hexokinase activity (GO:1903299) | 2.83352553 |
| 50 | defense response to protozoan (GO:0042832) | 2.81216721 |
| 51 | negative regulation of B cell apoptotic process (GO:0002903) | 2.80823919 |
| 52 | regulation of oxidative stress-induced neuron death (GO:1903203) | 2.79532254 |
| 53 | valine metabolic process (GO:0006573) | 2.78783501 |
| 54 | replication fork processing (GO:0031297) | 2.78419344 |
| 55 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.77684540 |
| 56 | regulation of growth of symbiont in host (GO:0044126) | 2.77684540 |
| 57 | negative regulation of growth of symbiont in host (GO:0044130) | 2.77684540 |
| 58 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.77684540 |
| 59 | response to protozoan (GO:0001562) | 2.73635460 |
| 60 | metallo-sulfur cluster assembly (GO:0031163) | 2.73544972 |
| 61 | iron-sulfur cluster assembly (GO:0016226) | 2.73544972 |
| 62 | response to muscle activity (GO:0014850) | 2.73150939 |
| 63 | cellular extravasation (GO:0045123) | 2.73078856 |
| 64 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.69892934 |
| 65 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.69564409 |
| 66 | negative regulation of acute inflammatory response (GO:0002674) | 2.69084735 |
| 67 | positive regulation of B cell differentiation (GO:0045579) | 2.68520641 |
| 68 | regulation of proton transport (GO:0010155) | 2.68497816 |
| 69 | cellular metabolic compound salvage (GO:0043094) | 2.66077483 |
| 70 | cellular response to zinc ion (GO:0071294) | 2.65873872 |
| 71 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.65186469 |
| 72 | xenobiotic catabolic process (GO:0042178) | 2.63869103 |
| 73 | leukotriene biosynthetic process (GO:0019370) | 2.63380862 |
| 74 | ADP metabolic process (GO:0046031) | 2.63259157 |
| 75 | galactose metabolic process (GO:0006012) | 2.61981180 |
| 76 | ubiquinone metabolic process (GO:0006743) | 2.59686515 |
| 77 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.59000590 |
| 78 | nucleotide salvage (GO:0043173) | 2.55490433 |
| 79 | NAD biosynthetic process (GO:0009435) | 2.55289127 |
| 80 | regulation of regulated secretory pathway (GO:1903305) | 2.53312708 |
| 81 | peptide hormone processing (GO:0016486) | 2.52106983 |
| 82 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.50951577 |
| 83 | cytokine biosynthetic process (GO:0042089) | 2.50535821 |
| 84 | negative regulation of mast cell activation (GO:0033004) | 2.48028688 |
| 85 | response to mercury ion (GO:0046689) | 2.47534940 |
| 86 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.46157568 |
| 87 | glycogen catabolic process (GO:0005980) | 2.45880848 |
| 88 | regulation of relaxation of muscle (GO:1901077) | 2.42061261 |
| 89 | immunoglobulin mediated immune response (GO:0016064) | 2.39755847 |
| 90 | phenol-containing compound biosynthetic process (GO:0046189) | 2.39624239 |
| 91 | autophagic vacuole fusion (GO:0000046) | 2.39543731 |
| 92 | regulation of cellular carbohydrate catabolic process (GO:0043471) | 2.39085624 |
| 93 | regulation of carbohydrate catabolic process (GO:0043470) | 2.39085624 |
| 94 | response to thyroid hormone (GO:0097066) | 2.38802719 |
| 95 | mannosylation (GO:0097502) | 2.38332150 |
| 96 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.38013617 |
| 97 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.36287215 |
| 98 | cytochrome complex assembly (GO:0017004) | 2.33930177 |
| 99 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.31131077 |
| 100 | short-chain fatty acid metabolic process (GO:0046459) | 2.29516942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 9.73512306 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.31508204 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.03861314 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.82572800 |
| 5 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.61339647 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.34978030 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.33738573 |
| 8 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.28980192 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.23000534 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13911893 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08187443 |
| 12 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04837914 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.04493264 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.00731255 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.00707209 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.96743888 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.85331158 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.82616298 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.82232341 |
| 20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77949055 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77907024 |
| 22 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.77368212 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.71756383 |
| 24 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.66986341 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57946296 |
| 26 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56431464 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.54087821 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.52962657 |
| 29 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.45104107 |
| 30 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.41834652 |
| 31 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.40864196 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.37136055 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36254161 |
| 34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.33659795 |
| 35 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32696064 |
| 36 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31391042 |
| 37 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.31270448 |
| 38 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30379733 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.29049715 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.28578873 |
| 41 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28202281 |
| 42 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.26414109 |
| 43 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.26408971 |
| 44 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.26288673 |
| 45 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.25659943 |
| 46 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.25144421 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.23121305 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22323629 |
| 49 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.21979217 |
| 50 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.20794646 |
| 51 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.15714451 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13512005 |
| 53 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.13182786 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12606399 |
| 55 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.12250265 |
| 56 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11774088 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10577634 |
| 58 | P300_27268052_Chip-Seq_Bcells_Human | 1.09630511 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09608763 |
| 60 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08825372 |
| 61 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.08123610 |
| 62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06855506 |
| 63 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05520465 |
| 64 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05415817 |
| 65 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.05409043 |
| 66 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.05064338 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.04323215 |
| 68 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.04207217 |
| 69 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04076808 |
| 70 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01253671 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00465858 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.00396097 |
| 73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99651008 |
| 74 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99254244 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98406600 |
| 76 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.97138817 |
| 77 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.96402314 |
| 78 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.95674568 |
| 79 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95142051 |
| 80 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.94051535 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91852367 |
| 82 | P68_20966046_ChIP-Seq_HELA_Human | 0.91718636 |
| 83 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.91301890 |
| 84 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.90868762 |
| 85 | MYB_26560356_Chip-Seq_TH1_Human | 0.89799875 |
| 86 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.89476053 |
| 87 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88464984 |
| 88 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.88459517 |
| 89 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.88015207 |
| 90 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.87838018 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87793162 |
| 92 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.87594434 |
| 93 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87501682 |
| 94 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87294745 |
| 95 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.87146883 |
| 96 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.87006031 |
| 97 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86635555 |
| 98 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.86410979 |
| 99 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.86397272 |
| 100 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86226891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 6.01175262 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.32751678 |
| 3 | MP0002735_abnormal_chemical_nociception | 3.11906829 |
| 4 | MP0009697_abnormal_copulation | 2.92511692 |
| 5 | MP0006036_abnormal_mitochondrial_physio | 2.86296555 |
| 6 | MP0005075_abnormal_melanosome_morpholog | 2.83094108 |
| 7 | MP0000372_irregular_coat_pigmentation | 2.72613298 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.63710598 |
| 9 | MP0009840_abnormal_foam_cell | 2.58405172 |
| 10 | MP0000749_muscle_degeneration | 2.26738142 |
| 11 | MP0008058_abnormal_DNA_repair | 2.24934958 |
| 12 | MP0002971_abnormal_brown_adipose | 2.15981612 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.15449424 |
| 14 | MP0000465_gastrointestinal_hemorrhage | 2.12204688 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.11824588 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.04059479 |
| 17 | MP0005451_abnormal_body_composition | 2.00679149 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 1.85369382 |
| 19 | MP0005397_hematopoietic_system_phenotyp | 1.84734492 |
| 20 | MP0001545_abnormal_hematopoietic_system | 1.84734492 |
| 21 | MP0003646_muscle_fatigue | 1.63911219 |
| 22 | MP0003638_abnormal_response/metabolism_ | 1.57030208 |
| 23 | MP0001873_stomach_inflammation | 1.55468639 |
| 24 | MP0009278_abnormal_bone_marrow | 1.55111900 |
| 25 | MP0009115_abnormal_fat_cell | 1.54682222 |
| 26 | MP0003195_calcinosis | 1.53143172 |
| 27 | MP0002419_abnormal_innate_immunity | 1.48977291 |
| 28 | MP0005171_absent_coat_pigmentation | 1.48170711 |
| 29 | MP0003718_maternal_effect | 1.48128721 |
| 30 | MP0001853_heart_inflammation | 1.44703638 |
| 31 | MP0005647_abnormal_sex_gland | 1.43379423 |
| 32 | MP0004036_abnormal_muscle_relaxation | 1.40690816 |
| 33 | MP0005330_cardiomyopathy | 1.39650165 |
| 34 | MP0010094_abnormal_chromosome_stability | 1.39115160 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.37971627 |
| 36 | MP0005025_abnormal_response_to | 1.36850714 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.32614213 |
| 38 | MP0003950_abnormal_plasma_membrane | 1.30527651 |
| 39 | MP0005387_immune_system_phenotype | 1.27658129 |
| 40 | MP0001790_abnormal_immune_system | 1.27658129 |
| 41 | MP0006082_CNS_inflammation | 1.27049333 |
| 42 | MP0005448_abnormal_energy_balance | 1.26235744 |
| 43 | MP0005410_abnormal_fertilization | 1.23255495 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.21393426 |
| 45 | MP0003075_altered_response_to | 1.18527419 |
| 46 | MP0009765_abnormal_xenobiotic_induced | 1.17043254 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.16665153 |
| 48 | MP0008469_abnormal_protein_level | 1.16660067 |
| 49 | MP0001819_abnormal_immune_cell | 1.16344179 |
| 50 | MP0005334_abnormal_fat_pad | 1.16197895 |
| 51 | MP0005166_decreased_susceptibility_to | 1.14683786 |
| 52 | MP0002452_abnormal_antigen_presenting | 1.14044594 |
| 53 | MP0003436_decreased_susceptibility_to | 1.13262824 |
| 54 | MP0002723_abnormal_immune_serum | 1.12647895 |
| 55 | MP0005266_abnormal_metabolism | 1.11794851 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.11435525 |
| 57 | MP0002405_respiratory_system_inflammati | 1.11219479 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 1.09609877 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.08817968 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.06086053 |
| 61 | MP0002970_abnormal_white_adipose | 1.05887189 |
| 62 | MP0000733_abnormal_muscle_development | 1.05298732 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.04811860 |
| 64 | MP0002733_abnormal_thermal_nociception | 1.04756401 |
| 65 | MP0002269_muscular_atrophy | 1.04643044 |
| 66 | MP0001800_abnormal_humoral_immune | 1.03329221 |
| 67 | MP0000747_muscle_weakness | 1.01192041 |
| 68 | MP0002722_abnormal_immune_system | 1.00869178 |
| 69 | MP0009785_altered_susceptibility_to | 1.00788587 |
| 70 | MP0000681_abnormal_thyroid_gland | 0.99370919 |
| 71 | MP0000716_abnormal_immune_system | 0.98402188 |
| 72 | MP0002108_abnormal_muscle_morphology | 0.98118540 |
| 73 | MP0005332_abnormal_amino_acid | 0.97868902 |
| 74 | MP0008961_abnormal_basal_metabolism | 0.96255958 |
| 75 | MP0001845_abnormal_inflammatory_respons | 0.94864180 |
| 76 | MP0003172_abnormal_lysosome_physiology | 0.94495529 |
| 77 | MP0001764_abnormal_homeostasis | 0.94070148 |
| 78 | MP0001661_extended_life_span | 0.93844237 |
| 79 | MP0002429_abnormal_blood_cell | 0.91493951 |
| 80 | MP0004145_abnormal_muscle_electrophysio | 0.91277339 |
| 81 | MP0003186_abnormal_redox_activity | 0.89228894 |
| 82 | MP0008004_abnormal_stomach_pH | 0.88772276 |
| 83 | MP0002398_abnormal_bone_marrow | 0.88659242 |
| 84 | MP0000689_abnormal_spleen_morphology | 0.88255927 |
| 85 | MP0004084_abnormal_cardiac_muscle | 0.87902880 |
| 86 | MP0002127_abnormal_cardiovascular_syste | 0.87870587 |
| 87 | MP0009763_increased_sensitivity_to | 0.87322728 |
| 88 | MP0003724_increased_susceptibility_to | 0.85474923 |
| 89 | MP0000759_abnormal_skeletal_muscle | 0.84724060 |
| 90 | MP0000343_altered_response_to | 0.84682249 |
| 91 | MP0003763_abnormal_thymus_physiology | 0.84049392 |
| 92 | MP0002118_abnormal_lipid_homeostasis | 0.83120201 |
| 93 | MP0002132_abnormal_respiratory_system | 0.81335932 |
| 94 | MP0001348_abnormal_lacrimal_gland | 0.81244798 |
| 95 | MP0001881_abnormal_mammary_gland | 0.80862686 |
| 96 | MP0002876_abnormal_thyroid_physiology | 0.80434038 |
| 97 | MP0000371_diluted_coat_color | 0.79522619 |
| 98 | MP0002160_abnormal_reproductive_system | 0.79101138 |
| 99 | MP0004087_abnormal_muscle_fiber | 0.78550699 |
| 100 | MP0010329_abnormal_lipoprotein_level | 0.78316832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 4.31313498 |
| 2 | Autoimmune thrombocytopenia (HP:0001973) | 3.66560112 |
| 3 | Rhabdomyolysis (HP:0003201) | 3.65416897 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 3.58194277 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.53737098 |
| 6 | Petechiae (HP:0000967) | 3.47881644 |
| 7 | Male infertility (HP:0003251) | 3.21617911 |
| 8 | Nemaline bodies (HP:0003798) | 3.21518163 |
| 9 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.15789990 |
| 10 | Failure to thrive in infancy (HP:0001531) | 3.11849210 |
| 11 | Myoglobinuria (HP:0002913) | 3.11565329 |
| 12 | Reduced antithrombin III activity (HP:0001976) | 3.11363201 |
| 13 | Increased muscle lipid content (HP:0009058) | 2.97170099 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 2.96555159 |
| 15 | Granulocytopenia (HP:0001913) | 2.91034471 |
| 16 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.81748224 |
| 17 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.81748224 |
| 18 | Autoimmune hemolytic anemia (HP:0001890) | 2.80624577 |
| 19 | Type I transferrin isoform profile (HP:0003642) | 2.80492562 |
| 20 | Agammaglobulinemia (HP:0004432) | 2.80223397 |
| 21 | Eosinophilia (HP:0001880) | 2.79040549 |
| 22 | Ragged-red muscle fibers (HP:0003200) | 2.76155169 |
| 23 | Hepatocellular necrosis (HP:0001404) | 2.75244668 |
| 24 | Renal Fanconi syndrome (HP:0001994) | 2.75103205 |
| 25 | Rimmed vacuoles (HP:0003805) | 2.74728357 |
| 26 | Rough bone trabeculation (HP:0100670) | 2.74193562 |
| 27 | EMG: myopathic abnormalities (HP:0003458) | 2.67415774 |
| 28 | Increased intramyocellular lipid droplets (HP:0012240) | 2.60808075 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.59681665 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.59681665 |
| 31 | Abnormality of glycolipid metabolism (HP:0010969) | 2.59681665 |
| 32 | Hepatic necrosis (HP:0002605) | 2.52806154 |
| 33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.50997387 |
| 34 | Generalized aminoaciduria (HP:0002909) | 2.49607488 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.48545237 |
| 36 | Premature graying of hair (HP:0002216) | 2.44247492 |
| 37 | Increased CSF lactate (HP:0002490) | 2.43992741 |
| 38 | Thrombocytosis (HP:0001894) | 2.41807995 |
| 39 | Panhypogammaglobulinemia (HP:0003139) | 2.41773146 |
| 40 | Lipid accumulation in hepatocytes (HP:0006561) | 2.41187135 |
| 41 | Increased cerebral lipofuscin (HP:0011813) | 2.39776552 |
| 42 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.39478971 |
| 43 | Abnormality of the prostate (HP:0008775) | 2.38586083 |
| 44 | Mitochondrial inheritance (HP:0001427) | 2.38158209 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 2.34368412 |
| 46 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.33320493 |
| 47 | Increased serum ferritin (HP:0003281) | 2.32195071 |
| 48 | Distal arthrogryposis (HP:0005684) | 2.31678825 |
| 49 | Muscle stiffness (HP:0003552) | 2.31169981 |
| 50 | Abnormality of eosinophils (HP:0001879) | 2.31004860 |
| 51 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.29469762 |
| 52 | Hyporeflexia of lower limbs (HP:0002600) | 2.26252208 |
| 53 | Hypokinesia (HP:0002375) | 2.26063590 |
| 54 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.25555906 |
| 55 | Recurrent viral infections (HP:0004429) | 2.23380560 |
| 56 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.22220907 |
| 57 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.21568648 |
| 58 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.21105957 |
| 59 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.21105957 |
| 60 | Abnormal protein glycosylation (HP:0012346) | 2.21105957 |
| 61 | Abnormal glycosylation (HP:0012345) | 2.21105957 |
| 62 | Acute necrotizing encephalopathy (HP:0006965) | 2.18768842 |
| 63 | Acute encephalopathy (HP:0006846) | 2.18200381 |
| 64 | Myopathic facies (HP:0002058) | 2.17987004 |
| 65 | Prolonged neonatal jaundice (HP:0006579) | 2.16877706 |
| 66 | Clumsiness (HP:0002312) | 2.16531319 |
| 67 | Calf muscle hypertrophy (HP:0008981) | 2.14684222 |
| 68 | Intrahepatic cholestasis (HP:0001406) | 2.11463423 |
| 69 | Abnormality of the basal ganglia (HP:0002134) | 2.10178789 |
| 70 | Dysostosis multiplex (HP:0000943) | 2.09715060 |
| 71 | Facial diplegia (HP:0001349) | 2.05268901 |
| 72 | Progressive macrocephaly (HP:0004481) | 2.04448072 |
| 73 | Colitis (HP:0002583) | 2.04383639 |
| 74 | Leukocytosis (HP:0001974) | 2.04301595 |
| 75 | Exercise-induced muscle cramps (HP:0003710) | 2.03028619 |
| 76 | Neck muscle weakness (HP:0000467) | 2.01420944 |
| 77 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.01378366 |
| 78 | Recurrent cutaneous fungal infections (HP:0011370) | 2.01378366 |
| 79 | Cerebral edema (HP:0002181) | 2.00531523 |
| 80 | Purpura (HP:0000979) | 1.97975642 |
| 81 | Hyperthyroidism (HP:0000836) | 1.96905374 |
| 82 | Absent thumb (HP:0009777) | 1.96239058 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 1.95657822 |
| 84 | Obstructive lung disease (HP:0006536) | 1.94052802 |
| 85 | Chronic obstructive pulmonary disease (HP:0006510) | 1.94052802 |
| 86 | Generalized hyperpigmentation (HP:0007440) | 1.93748169 |
| 87 | Orthostatic hypotension (HP:0001278) | 1.92843743 |
| 88 | Lethargy (HP:0001254) | 1.90948901 |
| 89 | Opisthotonus (HP:0002179) | 1.90937898 |
| 90 | Hyperammonemia (HP:0001987) | 1.90726605 |
| 91 | Asymmetric septal hypertrophy (HP:0001670) | 1.90055251 |
| 92 | Abnormal trabecular bone morphology (HP:0100671) | 1.89965643 |
| 93 | Thoracic kyphosis (HP:0002942) | 1.89589591 |
| 94 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.86820337 |
| 95 | Bone marrow hypocellularity (HP:0005528) | 1.85364234 |
| 96 | Acute hepatic failure (HP:0006554) | 1.84004985 |
| 97 | Cutaneous melanoma (HP:0012056) | 1.81791031 |
| 98 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.81486693 |
| 99 | Dicarboxylic aciduria (HP:0003215) | 1.81486693 |
| 100 | Abnormality of B cell number (HP:0010975) | 1.80908867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 6.74367033 |
| 2 | OBSCN | 4.26152352 |
| 3 | NME2 | 3.34651145 |
| 4 | PINK1 | 3.09571066 |
| 5 | FRK | 3.00076409 |
| 6 | IRAK3 | 2.59854305 |
| 7 | VRK2 | 2.53019765 |
| 8 | MARK3 | 2.39487097 |
| 9 | BCKDK | 2.30629514 |
| 10 | TAOK1 | 2.19191623 |
| 11 | GRK6 | 1.95891993 |
| 12 | MAPKAPK3 | 1.80610148 |
| 13 | TBK1 | 1.80342918 |
| 14 | KIT | 1.71360144 |
| 15 | SCYL2 | 1.59188816 |
| 16 | MAP4K1 | 1.59019938 |
| 17 | TYK2 | 1.58178733 |
| 18 | MATK | 1.50880924 |
| 19 | TRPM7 | 1.49427697 |
| 20 | PIK3CG | 1.45465402 |
| 21 | CSF1R | 1.40422586 |
| 22 | MAP2K3 | 1.40314808 |
| 23 | PHKG1 | 1.36795555 |
| 24 | PHKG2 | 1.36795555 |
| 25 | IKBKE | 1.35370793 |
| 26 | TAOK3 | 1.34275917 |
| 27 | FER | 1.34196661 |
| 28 | PDK2 | 1.33375046 |
| 29 | RPS6KB2 | 1.31458583 |
| 30 | KDR | 1.28972118 |
| 31 | ERN1 | 1.27671081 |
| 32 | GRK7 | 1.24991654 |
| 33 | ABL2 | 1.17165807 |
| 34 | PIM2 | 1.13706566 |
| 35 | CCNB1 | 1.10403616 |
| 36 | PBK | 1.08811500 |
| 37 | EIF2AK3 | 1.06776535 |
| 38 | TESK2 | 1.05141108 |
| 39 | MOS | 1.03191680 |
| 40 | MAP3K1 | 1.02209297 |
| 41 | IKBKB | 1.01202600 |
| 42 | ZAP70 | 0.97590400 |
| 43 | BMPR1B | 0.95700157 |
| 44 | EIF2AK1 | 0.93088202 |
| 45 | MAP3K11 | 0.92285674 |
| 46 | TGFBR2 | 0.91523949 |
| 47 | SYK | 0.88915427 |
| 48 | ARAF | 0.84914215 |
| 49 | BTK | 0.83799329 |
| 50 | MAP2K6 | 0.82980975 |
| 51 | STK16 | 0.82508172 |
| 52 | DAPK1 | 0.81295328 |
| 53 | TAOK2 | 0.71948450 |
| 54 | TEC | 0.70813847 |
| 55 | LYN | 0.68248379 |
| 56 | BMPR2 | 0.67825171 |
| 57 | TNK2 | 0.67454975 |
| 58 | RIPK4 | 0.64332245 |
| 59 | ADRBK2 | 0.64326549 |
| 60 | MUSK | 0.63034216 |
| 61 | TNIK | 0.61448052 |
| 62 | MAP3K13 | 0.59497312 |
| 63 | FES | 0.54312357 |
| 64 | PDK1 | 0.54091638 |
| 65 | GRK1 | 0.54023899 |
| 66 | CSNK1G3 | 0.53682386 |
| 67 | ATR | 0.52457754 |
| 68 | CAMK2G | 0.51391565 |
| 69 | CSNK1A1L | 0.51247870 |
| 70 | HIPK2 | 0.51068685 |
| 71 | MAP3K14 | 0.48305008 |
| 72 | PIK3CA | 0.48154351 |
| 73 | EEF2K | 0.47968036 |
| 74 | EIF2AK2 | 0.47749045 |
| 75 | MAPK12 | 0.46183758 |
| 76 | LCK | 0.46171116 |
| 77 | MAPKAPK5 | 0.45238142 |
| 78 | GRK5 | 0.44175126 |
| 79 | FLT3 | 0.44015309 |
| 80 | DAPK2 | 0.43908797 |
| 81 | VRK1 | 0.43457379 |
| 82 | PRKD2 | 0.42461318 |
| 83 | IRAK4 | 0.41848043 |
| 84 | CAMK2D | 0.41374878 |
| 85 | BLK | 0.41114804 |
| 86 | TTN | 0.40417380 |
| 87 | PAK1 | 0.39967893 |
| 88 | MAP2K2 | 0.39135938 |
| 89 | RPS6KA5 | 0.38658686 |
| 90 | STK38 | 0.38257374 |
| 91 | PRKCQ | 0.37362963 |
| 92 | MYLK | 0.35124947 |
| 93 | PDPK1 | 0.35020680 |
| 94 | CSNK1G1 | 0.34139513 |
| 95 | CDK3 | 0.34090220 |
| 96 | IRAK2 | 0.33504298 |
| 97 | ZAK | 0.32051367 |
| 98 | NUAK1 | 0.31231114 |
| 99 | ITK | 0.30022405 |
| 100 | AKT2 | 0.26814049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 3.97599923 |
| 2 | Histidine metabolism_Homo sapiens_hsa00340 | 3.83317461 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.71830674 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.78824844 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.46430284 |
| 6 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.95624988 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.93408171 |
| 8 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.91479477 |
| 9 | Peroxisome_Homo sapiens_hsa04146 | 1.82070308 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 1.77665048 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 1.74221276 |
| 12 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.64709003 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.60830511 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60577761 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57932471 |
| 16 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.57425090 |
| 17 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.56336070 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.53791231 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 1.49167670 |
| 20 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.48284918 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.46347519 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.41725095 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.41500436 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40182475 |
| 25 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.38959279 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.38808769 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.36040893 |
| 28 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.34065077 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.31938198 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31656110 |
| 31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.29770402 |
| 32 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.27486420 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.22780000 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.22509613 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.21579714 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21448779 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.20588869 |
| 38 | Parkinsons disease_Homo sapiens_hsa05012 | 1.18615977 |
| 39 | Mismatch repair_Homo sapiens_hsa03430 | 1.16149413 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15862673 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15286423 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13098072 |
| 43 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.12811840 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.12673257 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11372125 |
| 46 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.09960676 |
| 47 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.05828725 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.01972827 |
| 49 | Purine metabolism_Homo sapiens_hsa00230 | 1.01285449 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00260157 |
| 51 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.96886064 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.94776574 |
| 53 | Allograft rejection_Homo sapiens_hsa05330 | 0.94741854 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91726471 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.91600956 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88719796 |
| 57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.88109359 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87832754 |
| 59 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.85300037 |
| 60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.84970564 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79216693 |
| 62 | Metabolic pathways_Homo sapiens_hsa01100 | 0.77721689 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76027168 |
| 64 | RNA polymerase_Homo sapiens_hsa03020 | 0.73405139 |
| 65 | Leishmaniasis_Homo sapiens_hsa05140 | 0.72550005 |
| 66 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.71946544 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.70864255 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70848888 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.69958532 |
| 70 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69924532 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.64647166 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.61772369 |
| 73 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58443318 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57456264 |
| 75 | Phototransduction_Homo sapiens_hsa04744 | 0.56822199 |
| 76 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56759297 |
| 77 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56507834 |
| 78 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.56141992 |
| 79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.54634543 |
| 80 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53854125 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.52590213 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52363934 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51746726 |
| 84 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49289346 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45446131 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.44630877 |
| 87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.43580649 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43398591 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.42319849 |
| 90 | Ribosome_Homo sapiens_hsa03010 | 0.41006002 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.39816254 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39348851 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.37752668 |
| 94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37670088 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.34084924 |
| 96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.33975001 |
| 97 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.32981548 |
| 98 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.30176687 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29811745 |
| 100 | Tuberculosis_Homo sapiens_hsa05152 | 0.28109486 |

